Targets and emerging therapies for schizophrenia / edited by Jeffrey S. Albert, Michael W. Wood.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2012 |
Language: | English |
Online Access: | |
Physical Description: | xiii, 472 p., [4] p. of col. plates :; ill. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
500843663 |
---|---|
ctrlnum |
(MiAaPQ)500843663 (Au-PeEL)EBL843663 (CaPaEBR)ebr10580248 (CaONFJC)MIL367629 (OCoLC)769289644 |
collection |
bib_alma |
record_format |
marc |
spelling |
Targets and emerging therapies for schizophrenia [electronic resource] / edited by Jeffrey S. Albert, Michael W. Wood. Hoboken, N.J. : Wiley, 2012. xiii, 472 p., [4] p. of col. plates : ill. Includes bibliographical references and index. Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- A7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihaly Hajos, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard. Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Schizophrenia Treatment. Electronic books. Albert, Jeffrey S. Wood, Michael W. (Michael William), 1961- ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=843663 Click to View |
language |
English |
format |
Electronic eBook |
author2 |
Albert, Jeffrey S. Wood, Michael W. 1961- ProQuest (Firm) |
author_facet |
Albert, Jeffrey S. Wood, Michael W. 1961- ProQuest (Firm) ProQuest (Firm) |
author2_variant |
j s a js jsa m w w mw mww |
author2_fuller |
(Michael William), |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR |
author_corporate |
ProQuest (Firm) |
author_sort |
Albert, Jeffrey S. |
title |
Targets and emerging therapies for schizophrenia |
spellingShingle |
Targets and emerging therapies for schizophrenia Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- A7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihaly Hajos, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard. |
title_full |
Targets and emerging therapies for schizophrenia [electronic resource] / edited by Jeffrey S. Albert, Michael W. Wood. |
title_fullStr |
Targets and emerging therapies for schizophrenia [electronic resource] / edited by Jeffrey S. Albert, Michael W. Wood. |
title_full_unstemmed |
Targets and emerging therapies for schizophrenia [electronic resource] / edited by Jeffrey S. Albert, Michael W. Wood. |
title_auth |
Targets and emerging therapies for schizophrenia |
title_new |
Targets and emerging therapies for schizophrenia |
title_sort |
targets and emerging therapies for schizophrenia |
publisher |
Wiley, |
publishDate |
2012 |
physical |
xiii, 472 p., [4] p. of col. plates : ill. |
contents |
Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- A7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihaly Hajos, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard. |
isbn |
9781118309384 (electronic bk.) |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC514 |
callnumber-sort |
RC 3514 T37 42012 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=843663 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.89/8061 |
dewey-sort |
3616.89 48061 |
dewey-raw |
616.89/8061 |
dewey-search |
616.89/8061 |
oclc_num |
769289644 |
work_keys_str_mv |
AT albertjeffreys targetsandemergingtherapiesforschizophrenia AT woodmichaelw targetsandemergingtherapiesforschizophrenia AT proquestfirm targetsandemergingtherapiesforschizophrenia |
status_str |
n |
ids_txt_mv |
(MiAaPQ)500843663 (Au-PeEL)EBL843663 (CaPaEBR)ebr10580248 (CaONFJC)MIL367629 (OCoLC)769289644 |
is_hierarchy_title |
Targets and emerging therapies for schizophrenia |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1792330725494620160 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03318nam a2200373 a 4500</leader><controlfield tag="001">500843663</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">111222s2012 njuaf sb 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2011051091</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780470322826 (cloth)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118309384 (electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)500843663</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL843663</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10580248</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL367629</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)769289644</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC514</subfield><subfield code="b">.T37 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.89/8061</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Targets and emerging therapies for schizophrenia</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">edited by Jeffrey S. Albert, Michael W. Wood.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Hoboken, N.J. :</subfield><subfield code="b">Wiley,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiii, 472 p., [4] p. of col. plates :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- A7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihaly Hajos, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Schizophrenia</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Albert, Jeffrey S.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wood, Michael W.</subfield><subfield code="q">(Michael William),</subfield><subfield code="d">1961-</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=843663</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |